EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
CrossAmerica Partners LP
CAPL

CAPL CrossAmerica Partners LP

CrossAmerica Partners LP · NYSE
Market Closed
22.80
▼ ⁦-0.44%⁩ (-0.10)
Market Cap$873.7M
Beta0.28
52w Low52w High
19.6724.63
Last Week
⁦-1.04%⁩
Last Month
⁦+6.49%⁩
Last 3 Months
⁦+5.46%⁩
Last Year
⁦+9.46%⁩
EL7 Factor Analysis
How we score this
Overall46
Balanced — near the middle of the marketSuper StockF 7/9Better than 46% of Market stocks, per EL7's modelUnsustainable dividend (payout > 100%)
FactorScoreDistributionValueAvgRank
▸
Valuation
76
16.5x▲17.8xTop tier
▸
Growth
15
0.3%▼7.1%Bottom tier
▸
Quality
58
11.8%▲4.5%Around median
▸
Safety
31
5.1x▼2.6xBottom tier
▸
Capital Return
39
9.20%▲2.12%Bottom tier
▸
Momentum
74
3.3%▲2.9%Top tier
▸
Sentiment
24
1▼3Bottom tier

Frequently Asked Questions

What is CrossAmerica Partners LP stock?▼

CrossAmerica Partners LP is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.

How can I invest in CrossAmerica Partners LP?▼

You can buy CrossAmerica Partners LP shares through a licensed brokerage. Research the company's financials before investing.

What are the key metrics for evaluating CrossAmerica Partners LP?▼

Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.

Does CrossAmerica Partners LP pay dividends?▼

Dividend policies vary by company. Check the dividends section on the stock page for the payout history.

What are the risks of investing in CrossAmerica Partners LP?▼

Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.

Fair Value
Low confidenceCurrent price$23
Analyst target
No data
vs
DCF (estimate)
$23
⁦+3%⁩
Sees it fairly priced
⁦7.9⁩% discount · ⁦0⁩% growth

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener

AI analysis from the earnings call, financials and news

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target
—
Current Price $22.80
Analyst coverage
15
Recent analyst moves
  • = Reiterate2021-12-16
    Wells Fargo
    Underweight
  • ⬇ Downgrade2021-04-15
    Raymond James
    OutperformMarket Perform
  • = Reiterate2021-01-14
    Raymond James
    Outperform
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    16.52x
    3.56x28.47x
    Cheap
  • Forward P/E
    30.00x
    3.36x26.89x
    Expensive
  • EV / EBITDA
    9.77x
    2.12x16.98x
    Near median
  • FCF Yield
    12.0%
    -21.0%15.7%
    Strong
  • Revenue Growth YoY
    0.3%
    -19.7%63.1%
    Below average
  • EPS Growth YoY
    22.1%
    -141.8%256.7%
    Near median
  • Gross Margin
    10.9%
    7.8%72.1%
    Weak
  • ROIC
    11.8%
    -12.7%20.6%
    Strong
  • Net Debt / EBITDA
    5.10x
    0.40x3.19x
    High debt
  • Dividend Yield
    9.2%
    0.4%10.1%
    High
  • Payout Ratio
    152.0%
    11.9%109.0%
    High
  • Altman Z-Score
    —
    —
Financial Analysis
|